Novo Nordisk (NVO) is down -20.0%, or -$20.66 to $82.78.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- BTIG reiterates Buy on Viking Therapeutics after Novo’s CagriSema ‘underwhelms’
- Novo Nordisk (NYSE:NVO) Slides as Weight-Loss Drug Trial Misses Expectations
- Morning Movers: Lilly rises, Novo Nordisk falls following CagriSema trial data
- Novo Nordisk Initiates Major Share Repurchase Program
- Eli Lilly Stock Soars as FDA Ends Weight Loss Drug Shortage